We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.62%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
APFBOT
301
Amica Pension Fund Board of Trustees
Rhode Island
$225K +$204K +4,140 New
MCIM
302
Meadow Creek Investment Management
Georgia
$223K +$202K +4,092 New
FDCDDQ
303
Federation des caisses Desjardins du Quebec
Quebec, Canada
$221K +$200K +4,063 New
IAM
304
Iridian Asset Management
Connecticut
$218K +$197K +4,000 New
PA
305
Pinnacle Associates
New York
$217K +$196K +3,979 New
SFA
306
Sequoia Financial Advisors
Ohio
$216K +$195K +3,963 New
LTFS
307
Ladenburg Thalmann Financial Services
Florida
$213K +$192K +3,902 New
FIM
308
FourPoints Investment Managers
France
$213K +$193K +3,913 New
PS
309
Pensionfund Sabic
Netherlands
$210K +$190K +3,850 New
LBC
310
Lawrence B. Cohen
$208K +$188K +3,812 New
BC
311
Burney Company
Virginia
$205K +$185K +3,760 New
AW
312
ACG Wealth
Georgia
$203K +$184K +3,727 New
FPF
313
FNY Partners Fund
New York
$198K +$180K +3,645 New
AAM
314
Advisors Asset Management
Colorado
$191K +$173K +3,512 New
Robeco Institutional Asset Management
315
Robeco Institutional Asset Management
Netherlands
$189K +$171K +3,472 New
NIPH
316
NN Investment Partners Holdings
Netherlands
$184K +$166K +3,375 New
SLI
317
Sumitomo Life Insurance
Japan
$183K +$166K +3,364 New
MPWT
318
MassMutual Private Wealth & Trust
Connecticut
$183K +$165K +3,354 New
TWA
319
TCI Wealth Advisors
Arizona
$176K +$159K +3,224 New
CIM
320
CenturyLink Investment Management
Colorado
$164K +$148K +3,005 New
FCM
321
Flinton Capital Management
Pennsylvania
$162K +$147K +2,976 New
CBOA
322
Commonwealth Bank of Australia
Australia
$160K +$145K +2,943 New
AG
323
Advisor Group
Arizona
$140K +$126K +2,554 New
Asset Management One
324
Asset Management One
Japan
$131K +$122K +2,477 New
Bessemer Group
325
Bessemer Group
New Jersey
$124K +$112K +2,280 New
11 12
13
14 15

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.